GlassScriptPhysician profile
Lawrence H Newman
NPI 1568528677
$21,784.63
in general payments reported to CMS, 2019-2025
57 companies · $3,681 in 2025
The $3,681 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,322 · 2020: $423 · 2021: $2,407 · 2022: $8,483 · 2023: $2,341 · 2024: $3,129 · 2025: $3,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,402 · Consulting Fee: $400 · Education: $224 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,401.75 |
| Consulting Fee | $400.00 |
| Education | $223.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $8,564.16 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $1,259.57 | 2023-2025 | Gemtesa, Orgovyx |
| Cipla USA INC. | $1,120.48 | 2021 | |
| Boston Scientific Corporation | $959.38 | 2019-2025 | Spaceoar System, Spaceoar Vue System - 10ml, General - Erectile Dysfunction |
| Astellas Pharma US INC | $953.64 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Janssen Biotech, INC. | $783.37 | 2019-2025 | Erleada |
| Abbvie INC. | $632.95 | 2022-2025 | |
| Urogen Pharma, INC. | $622.55 | 2021-2025 | Jelmyto |
| Pfizer INC. | $531.90 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $418.40 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Telix Pharmaceuticals | $400.34 | 2023-2025 | Illuccix |
| Urovant Sciences INC | $355.33 | 2021-2022 | |
| Amgen INC. | $351.03 | 2019-2023 | Xgeva |
| Bayer Healthcare Pharmaceuticals INC. | $345.22 | 2019-2025 | |
| Antares Pharma, INC. | $312.58 | 2019-2025 | Xyosted, Tlando, Nocdurna |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $306.05 | 2019 | |
| Procept Biorobotics Corporation | $267.70 | 2022-2023 | Aquabeam Robotic System |
| Myovant Sciences INC. | $245.77 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $227.55 | 2019-2024 | Xiaflex |
| Hollister Incorporated | $211.46 | 2020-2022 | |
| Accord Healthcare, INC. | $198.51 | 2023-2025 | |
| Angiodynamics, INC. | $194.26 | 2023 | Nanoknife |
| Progenics Pharmaceuticals, INC. | $189.82 | 2022-2024 | Pylarify |
| Myriad Genetic Laboratories, INC. | $179.57 | 2020-2025 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $164.03 | 2022-2023 | Imfinzi |
| Medtronic, INC. | $161.66 | 2025 | Interstim |
| Blue Earth Diagnostics | $140.57 | 2021-2025 | Posluma |
| Olympus America INC. | $130.81 | 2019-2025 | Itind System |
| Edap Technomed INC | $125.00 | 2023 | |
| Verity Pharmaceuticals INC. | $124.96 | 2023-2024 | Trelstar |
| 180 Medical, INC. | $110.66 | 2019-2025 | Gentlecath Glide |
| Coloplast Corp | $106.95 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $103.47 | 2023 | Model 200 Theraseed Palladium-103 In Readylink |
| Ferring Pharmaceuticals INC. | $96.22 | 2019-2025 | Adstiladrin |
| Endo USA, INC. | $85.90 | 2024-2025 | Xiaflex |
| Calyxo, INC. | $85.62 | 2025 | Cvac Aspiration System |
| Intuitive Surgical, INC. | $84.97 | 2019 | |
| Sun Pharmaceutical Industries INC. | $68.04 | 2019-2022 | |
| Immunitybio, INC. | $50.94 | 2025 | |
| Palette Life Sciences, INC. | $49.55 | 2022 | |
| Teleflex LLC | $45.05 | 2024-2025 | Urolift |
| Bioprotect Medical, INC. | $42.79 | 2024 | Bioprotect Balloon Implant System |
| Tempus Ai, INC | $41.85 | 2024-2025 | Xt Cdx |
| Tolmar Pharmaceuticals, INC. | $39.46 | 2022 | |
| Allergan, INC. | $38.38 | 2021 | |
| Tolmar, INC. | $37.14 | 2023 | |
| Novartis Pharmaceuticals Corporation | $30.65 | 2025 | |
| Laborie Medical Technologies Corp. | $24.69 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Alnylam Pharmaceuticals INC. | $23.69 | 2022 | |
| Karl Storz Endoscopy-America | $23.60 | 2025 | |
| Innovation Technologies INC | $23.21 | 2024 | Irrisept |
| Halozyme INC | $21.24 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $18.20 | 2025 | |
| Abc Home Medical Supply, INC. | $14.69 | 2025 | |
| Mission Pharmacal Company | $14.22 | 2023 | Uribel |
| Rochester Medical Corporation | $13.16 | 2020 | |
| Axonics, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.